Cite

HARVARD Citation

    Reisi, N. et al. (2022). Therapeutic potential of silymarin as a natural iron‐chelating agent in β‐thalassemia intermedia. Clinical case reports. 10 (1), p. n/a. [Online]. 
  
Back to record